Examining the Impact of Biopsy Technique on Clinical and Pathologic Outcomes in Dermatofibrosarcoma Protuberans: An International, Multi-Institutional Study
Language English Country United States Media print-electronic
Document type Journal Article, Multicenter Study
Grant support
P30CA006927
NCI NIH HHS - United States
P30CA006927
NCI NIH HHS - United States
PubMed
40014211
DOI
10.1245/s10434-025-17011-7
PII: 10.1245/s10434-025-17011-7
Knihovny.cz E-resources
- Keywords
- Circumferential margins, Dermatofibrosarcoma protuberans (DFSP), Excisional biopsy, Preoperative biopsy, Unplanned excision,
- MeSH
- Biopsy methods MeSH
- Dermatofibrosarcoma * pathology surgery MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Skin Neoplasms * pathology surgery MeSH
- Follow-Up Studies MeSH
- Prognosis MeSH
- Margins of Excision MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
BACKGROUND: The National Comprehensive Cancer Network (NCCN) guidelines recommend preoperative biopsy for diagnosing dermatofibrosarcoma protuberans (DFSP) but limited data support this approach. We characterized DFSP diagnostic practices and compared clinical outcomes based on technique. METHODS: Data were collected for adult patients who underwent resection for initial DFSP presentation between 2003 and 2021 at 10 international institutions. Patients were categorized by excisional versus preoperative biopsy (incisional, punch, core needle biopsies, or fine needle aspiration), and univariate and multivariable analyses were performed. RESULTS: The cohort included 321 patients, with excisional biopsy performed in 51.4% and preoperative biopsy performed in 48.6% of patients. Biopsy type was stable throughout the study period (p = 0.08). There were no differences in sex, disease presentation, or preoperative imaging. In unadjusted analysis, biopsy varied by practitioner specialty, with general surgeons performing nearly 50% of excisional biopsies. Despite similar planned circumferential margins and anatomic location, preoperative biopsy was associated with higher index R0 rate (60.1% vs. 78.6%), fewer total excisions, and fewer complications (38.2% vs. 25.6%, all p < 0.05). However, adjuvant radiotherapy (11.7% vs. 6.0%) and final R0 rates (91.5% vs. 88.4%) were comparable regardless of technique (p > 0.05). In adjusted analysis, excisional biopsy was associated with extremity tumors (odds ratio [OR] 1.79, confidence interval [CI] 1.21-2.66, p = 0.004), treatment in non-academic settings (OR 2.28, CI 1.10-4.73, p = 0.03), and inversely with preoperative imaging (OR 0.47, CI 0.24-0.93, p = 0.03). CONCLUSION: Preoperative biopsy is associated with margin-negative resection, fewer re-excisions, and reduced complications. Clinical suspicion of DFSP is paramount, and preoperative imaging may critically inform biopsy selection prior to index resection.
Department of General Surgery Temple University Hospital Philadelphia PA USA
Department of Medical Oncology Bern University Hospital University of Bern Bern Switzerland
Department of Musculoskeletal Oncology National Cancer Center Hospital Tokyo Japan
Department of Surgery Duke University Hospital Durham NC USA
Department of Surgical Oncology University Hospitals Leuven Leuven Belgium
Division of Biostatistics and Bioinformatics Fox Chase Cancer Center Philadelphia PA USA
Division of Hematology and Medical Oncology Fox Chase Cancer Center Philadelphia PA USA
Division of Surgery Institute of Oncology Ljubljana Ljubljana Slovenia
Division of Surgical Oncology Emory University Hospital Atlanta GA USA
Division of Surgical Oncology Fox Chase Cancer Center Philadelphia PA USA
Division of Surgical Oncology Ottawa Hospital Ottawa ON Canada
See more in PubMed
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Dermatofibrosarcoma Protbuerans. Version 1.2023. National Comprehensive Cancer Network. Available at: https://www.nccn.org/professionals/physician_gls/pdf/dfsp.pdf . Accessed 22 April 2023,
Winer LK, Akumuo R, Fredette JD, et al. Current patterns of care and outcomes for dermatofibrosarcoma protuberans: an international multi-institutional collaborative. Cancer. 2025;131(1):e35468. https://doi.org/10.1002/cncr.35468 . PubMed DOI
Zaidi MY, Ethun CG, Liu Y, et al. The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: a multi-institutional propensity score analysis from the US sarcoma collaborative. J Surg Oncol. 2019;120(3):332–9. https://doi.org/10.1002/jso.25521 . PubMed DOI
Pretell-Mazzini J, Barton MD Jr, Conway SA, Temple HT. Unplanned excision of soft-tissue sarcomas: current concepts for management and prognosis. J Bone Joint Surg Am. 2015;97(7):597–603. https://doi.org/10.2106/JBJS.N.00649 . PubMed DOI
Grignol VP, Lopez-Aguiar AG. The implications of an unplanned sarcoma excision (the “whoops” operation). Surg Clin North Am. 2022;102(4):529–38. https://doi.org/10.1016/j.suc.2022.04.002 . PubMed DOI
Gouin F, Stoeckle E, Honore C, et al. Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort analysis. BMC Cancer. 2022;22(1):1034. https://doi.org/10.1186/s12885-022-10121-5 . PubMed DOI PMC
Smolle MA, Tunn PU, Goldenitsch E, et al. The prognostic impact of unplanned excisions in a cohort of 728 soft tissue sarcoma patients: a multicentre study. Ann Surg Oncol. 2017;24(6):1596–605. https://doi.org/10.1245/s10434-017-5776-8 . PubMed DOI PMC
Gomez-Alvarez J, Lamo-Espinosa JM, San-Julian M. Do Patients treated with an unplanned resection for small superficial soft tissue sarcomas have worse long-term survival than those initially treated with an oncologic resection? Clin Orthop Relat Res. 2024;482(6):1017–24. https://doi.org/10.1097/CORR.0000000000002974 . PubMed DOI
Harati K, Lange K, Goertz O, et al. A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control. World J Surg Oncol. 2017;15(1):5. https://doi.org/10.1186/s12957-016-1075-2 . PubMed DOI PMC
Monnier D, Vidal C, Martin L, et al. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002. J Eur Acad Dermatol Venereol. 2006;20(10):1237–42. https://doi.org/10.1111/j.1468-3083.2006.01780.x . PubMed DOI
Farma JM, Ammori JB, Zager JS, et al. Dermatofibrosarcoma protuberans: how wide should we resect? Ann Surg Oncol. 2010;17(8):2112–8. https://doi.org/10.1245/s10434-010-1046-8 . PubMed DOI
DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer. 2004;100(5):1008–16. https://doi.org/10.1002/cncr.20051 . PubMed DOI
Heuvel ST, Suurmeijer A, Pras E, Van Ginkel RJ, Hoekstra HJ. Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins. Eur J Surg Oncol. 2010;36(1):89–94. https://doi.org/10.1016/j.ejso.2009.07.006 . PubMed DOI
Meguerditchian AN, Wang J, Lema B, Kraybill WG, Zeitouni NC, Kane JM 3rd. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans. Am J Clin Oncol. 2010;33(3):300–3. https://doi.org/10.1097/COC.0b013e3181aaca87 . PubMed DOI
Snow H, Davies E, Strauss DC, Smith M, Hayes AJ. Conservative re-excision is a safe and simple alternative to radical resection in revision surgery for dermatofibrosarcoma protuberans. Ann Surg Oncol. 2020;27(3):919–23. https://doi.org/10.1245/s10434-019-08011-5 . PubMed DOI
Cable MG, Randall RL. Extremity soft tissue sarcoma: tailoring resection to histologic subtype. Surg Oncol Clin N Am. 2016;25(4):677–95. https://doi.org/10.1016/j.soc.2016.05.014 . PubMed DOI
Pavlidis ET, Pavlidis TE. New trends in the surgical management of soft tissue sarcoma: the role of preoperative biopsy. World J Clin Oncol. 2023;14(2):89–98. https://doi.org/10.5306/wjco.v14.i2.89 . PubMed DOI PMC
Blay JY, Honore C, Stoeckle E, et al. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann Oncol. 2019;30(8):1407. https://doi.org/10.1093/annonc/mdz170 . PubMed DOI PMC
Loong HH, Blay JY, Munhoz RR. International collaborations and regional challenges in providing specialist multidisciplinary sarcoma care. Am Soc Clin Oncol Educ Book. 2019;39:616–23. https://doi.org/10.1200/EDBK_239131 . PubMed DOI
Alcindor T, Dumitra S, Albritton K, Thomas DM. Disparities in cancer care: the example of sarcoma-in search of solutions for a global issue. Am Soc Clin Oncol Educ Book. 2021;41:1–7. https://doi.org/10.1200/EDBK_320463 . PubMed DOI